The Claim
Anti-thyroid medications are associated with the occurrence of rare but serious hepatotoxicity and bone marrow suppression in humans.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Anti-thyroid medications can lead to rare but severe liver damage and reduced production of blood cells in the bone marrow.
See the scientific wording
Anti-thyroid medications can cause rare but serious hepatotoxicity and bone marrow suppression.
The liver breaks down thyroid medications into highly reactive chemicals that stick to liver proteins, causing the immune system to attack liver cells and neutrophils. This leads to liver cell death and a drop in white blood cells, resulting in liver failure and reduced blood cell production.
What the research says
2 studiesThis study shows that a medicine used for an overactive thyroid, called PTU, can very rarely cause serious harm to the liver and stop the bone marrow from making enough blood cells — exactly what the claim says.
Study: Severe Liver Dysfunction Within 48 Hours of Thionamide Therapy in Thyrotoxicosis: A Case Report
This study shows that a rare but very serious liver injury can happen very quickly after taking certain thyroid medications, which supports the idea that these drugs can cause dangerous side effects—even if they’re uncommon.
Related videos
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 2 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.